Results 11 to 20 of about 40,902 (256)

Pulmonary Arterial Hypertension and Insulin Resistance [PDF]

Journal of Molecular and Genetic Medicine, 2014
The clinical recognition of pulmonary arterial hypertension (PAH) is increasing, and with recent therapeutic advances, short-term survival has improved. In spite of these advances, however, PAH remains a disease with substantial morbidity and long-term mortality.
Bradley, Elisa A, Bradley, David
openaire   +2 more sources

The incidence of cardiovascular and cerebrovascular complications in patients with uncontrolled hypertension

Терапевтический архив, 2022
Aim. To assess the incidence of cardiovascular and cerebrovascular events in patients with controlled and uncontrolled hypertension, controlled resistant and uncontrolled resistant hypertension, refractory hypertension, and probably resistant and ...
Anastasiya R. Denisova, Tatyana D. Solntseva, Aihanum S. Zarmanbetova, Alina A. Tkacheva, Olga A. Sivakova, Irina Е. Chazova   +5 more
doaj   +1 more source

7th Brazilian Guideline of Arterial Hypertension: Chapter 13 - Resistant Arterial Hypertension [PDF]

Arq Bras Cardiol, 2016
Malachias MVB, Rodrigues CI, Muxfeldt E, Salles GF, Moreno H, Gus M.   +5 more
europepmc   +3 more sources

Insulin resistance in pulmonary arterial hypertension [PDF]

European Respiratory Journal, 2008
Although obesity, dyslipidemia and insulin resistance (IR) are well known risk factors for systemic cardiovascular disease, their impact on pulmonary arterial hypertension (PAH) is unknown. The present authors’ previous studies indicate that IR may be a risk factor for PAH. The current study has investigated the prevalence of IR in PAH and explored its
R T, Zamanian, G, Hansmann, S, Snook, D, Lilienfeld, K M, Rappaport, G M, Reaven, M, Rabinovitch, R L, Doyle   +7 more
openaire   +2 more sources

Comparative Study of Methods of Differential Diagnosis of Essential Resistant and Pseudoresistant Arterial Hypertension in the Practice of Doctor of General Practice

Львівський клінічний вісник, 2018
Introduction. The prevalence of arterial hypertension in Ukraine reaches 35.0 % among the adult population. The frequency of cases of resistant hypertension in the population of patients with hypertension varies from 5.0 to 18.0 %.
О. Б. Волошина, В. О. Збітнєва, І. С. Лисий , Т. О. Дичко, В. В. Саморукова, О. Р. Дукова   +5 more
doaj   +1 more source

Treatment of Resistant Hypertension in Real Clinical Settings

Рациональная фармакотерапия в кардиологии, 2021
Background. Current guidelines describe in detail the approaches to the management of patients with resistant hypertension, however, in real clinical settings the number of non-rational and ineffective combinations of antihypertensive drugs used remains ...
A. S. Maltseva, A. E. Tsygankova, M. A. Gabitova, A. V. Rodionov, V. V. Fomin   +4 more
doaj   +1 more source

Novel approaches to treat resistant hypertension [PDF]

Българска кардиология, 2020
Treatment-resistant hypertension, or resistant hypertension (RH), is defined as arterial hypertension (AH) despite treatment with three properly dosed antihypertensive drugs, at least one of which is a diuretic.
Aleksandra Cherneva, Ivo Petrov
doaj   +3 more sources

Sodium Balance and Peripheral Resistance in Arterial Hypertension [PDF]

Journal of Cardiovascular Pharmacology, 1984
In this brief review, some aspects of the relation between sodium balance and peripheral resistance in four types of arterial hypertension are discussed. Renal hypertension, hypertension caused by reduced kidney mass and sodium load, mineralocorticoid hypertension, and spontaneous or "genetic" hypertension in rats are considered.
G. Bianchi, D. Cusi, C. Barlassina, C. Pati, M. G. Tripodi, E. Niutta, G. Vezzoli   +6 more
openaire   +3 more sources

Resistant arterial hypertension: problems and opportunities for personalised drug therapy

Кубанский научный медицинский вестник, 2020
Background. Effective drug therapy for resistant arterial hypertension is among major problems in modern medicine. The actual prevalence of resistant arterial hypertension is unknown, and its pathogenetic mechanisms are actively investigated.
A. V. Fendrikova, V. V. Skibitskiy, E. S. Garkusha, A. I. Chesnikova, M. Е. Statsenko   +4 more
doaj   +1 more source

Increased arterial stiffness causing resistant hypertension in an adolescent with Neurofibromatosis type 1 [PDF]

Kosin Medical Journal, 2018
Neurofibromatosis type 1 is an autosomal dominant genetic disorder characterized by the presence of café au lait spots, axillary and inguinal freckling, Lisch nodules, and neurofibromas.
Min Jung Cho
doaj   +1 more source